Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2016 1
2018 1
2019 1
2020 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma.
Tarone L, Giacobino D, Camerino M, Maniscalco L, Iussich S, Parisi L, Giovannini G, Dentini A, Bolli E, Quaglino E, Merighi IF, Morello E, Buracco P, Riccardo F, Cavallo F. Tarone L, et al. Among authors: merighi if. Mol Ther. 2023 Aug 2;31(8):2342-2359. doi: 10.1016/j.ymthe.2023.06.004. Epub 2023 Jun 12. Mol Ther. 2023. PMID: 37312451
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
Di Lorenzo A, Bolli E, Ruiu R, Ferrauto G, Di Gregorio E, Avalle L, Savino A, Poggio P, Merighi IF, Riccardo F, Brancaccio M, Quaglino E, Cavallo F, Conti L. Di Lorenzo A, et al. Among authors: merighi if. Oncoimmunology. 2022 Jun 15;11(1):2086752. doi: 10.1080/2162402X.2022.2086752. eCollection 2022. Oncoimmunology. 2022. PMID: 35756841 Free PMC article.
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.
Bandini S, Macagno M, Hysi A, Lanzardo S, Conti L, Bello A, Riccardo F, Ruiu R, Merighi IF, Forni G, Iezzi M, Quaglino E, Cavallo F. Bandini S, et al. Among authors: merighi if. Oncoimmunology. 2016 Nov 8;5(12):e1253653. doi: 10.1080/2162402X.2016.1253653. eCollection 2016. Oncoimmunology. 2016. PMID: 28123895 Free PMC article.
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial.
Riccardo F, Tarone L, Camerino M, Giacobino D, Iussich S, Barutello G, Arigoni M, Conti L, Bolli E, Quaglino E, Merighi IF, Morello E, Dentini A, Ferrone S, Buracco P, Cavallo F. Riccardo F, et al. Among authors: merighi if. J Immunother Cancer. 2022 May;10(5):e004007. doi: 10.1136/jitc-2021-004007. J Immunother Cancer. 2022. PMID: 35580930 Free PMC article.
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy.
Rolla S, Ria F, Occhipinti S, Di Sante G, Iezzi M, Spadaro M, Nicolò C, Ambrosino E, Merighi IF, Musiani P, Forni G, Cavallo F. Rolla S, et al. Among authors: merighi if. J Immunol. 2010 Jun 1;184(11):6124-32. doi: 10.4049/jimmunol.0901215. Epub 2010 Apr 30. J Immunol. 2010. PMID: 20435927